Paper Details 
Original Abstract of the Article :
OBJECTIVE: To evaluate the incidence of side-effects of oral and intravesical oxybutynin chloride in children with meningomyelocele (MMC) and a neurogenic bladder. PATIENTS AND METHODS: The study comprised 225 children with a neurogenic bladder from MMC who were evaluated with urodynamic testing an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1046/j.1464-410x.2001.02152.x

データ提供:米国国立医学図書館(NLM)

Oxybutynin for Spina Bifida: A Camel's Journey Through the Desert of Urological Challenges

The world of pediatric urology, like a vast and complex desert, presents unique challenges. This study, like a caravan traversing the sands of research, explores the use of oxybutynin, a medication used to treat bladder dysfunction, in children with spina bifida. The researchers, like skilled desert guides, carefully navigate the intricacies of treatment options, seeking to optimize outcomes for children with this condition. Their goal is to provide insights into the safest and most effective approaches for managing bladder dysfunction.

A Desert Oasis of Relief: The Findings Revealed

The researchers, like meticulous cartographers, map the terrain of oxybutynin treatment. They find that while both oral and intravesical administration of oxybutynin can be effective, intravesical administration, like a refreshing oasis in the desert, is generally better tolerated. However, they also highlight the potential for cognitive side effects, reminding us that even the most effective treatments can have unforeseen consequences.

Navigating the Desert of Urological Care: Implications for Life

This study, like a signpost pointing the way, emphasizes the importance of careful monitoring and individualized treatment approaches for children with spina bifida. Just as a camel adapts to its desert environment, these children require ongoing support and specialized care to manage their unique needs. This research provides valuable insights for healthcare providers to ensure the best possible outcomes for these patients.

Dr. Camel's Conclusion

This study, like a caravan leaving its mark on the desert sands, represents a significant step forward in our understanding of oxybutynin treatment for children with spina bifida. While intravesical administration offers a safer alternative to oral therapy, the potential for cognitive side effects underscores the importance of careful monitoring and individualized care. Just as a camel navigates the desert landscape, we must continue to seek new knowledge and innovative approaches to ensure the best possible outcomes for children facing these challenges.

Date :
  1. Date Completed 2001-06-14
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

11350411

DOI: Digital Object Identifier

10.1046/j.1464-410x.2001.02152.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.